Ahrens Investment Partners »

GSK shares owned by Ahrens Investment Partners

Quarter-by-quarter ownership of GSK (GSK) shares owned by Ahrens Investment Partners from 13F filings

Historical chart of Ahrens Investment Partners investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Ahrens Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Ahrens Investment Partners

Quarter filed Position value Share count Share price at filing
2023-03-31 $96k 2.7k 35.58

More positions owned by Ahrens Investment Partners

Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
First Tr Value Line Divid In SHS (FVD)
Ishares Tr Msci Usa Min Vol (USMV)
Apple (AAPL)
Fidelity Covington Trust Low Volity Etf (FDLO)
Ishares Tr U.s. Med Dvc Etf (IHI)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Virtus Etf Tr Ii Virtus Us Qlty (JOET)
Exxon Mobil Corporation (XOM)
Chevron Corporation (CVX)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Global X Fds Glb X Mlp Enrg I (MLPX)
DNP Select Income Fund (DNP)
Microsoft Corporation (MSFT)

View all positions for Ahrens Investment Partners

Top funds holding GSK

Dodge & Cox
JTC Employer Solutions Trustee
Fisher Investments
PRIMECAP Management Company
T. Rowe Price Associates
Royal Bank of Canada
Mondrian Investment Partners
Acadian Asset Management
Provident Trust
Arrowstreet Capital, Limited Partnership
Hotchkis and Wiley Capital Management
Equity Investment Corp Acquisition
Dimensional Fund Advisors
Renaissance Technologies
Bank of America Corporation

View all funds holding GSK